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year-old woman is described. The lesion grew out of an extraction socket and enlarged rapidly.
Radiographically, a large radiolucent lesion with ill-defined margins was observed in the left pos-
terior mandible. Histopathologically, islands of odontogenic epithelium with a surrounding
malignant mesenchymal proliferation were noted. The latter exhibited hyperchromatic oval
and spindle-shaped cells with 3–4 mitoses in some high-power fields and foci of necrosis.
Lesional cells demonstrated immunoreactivity with vimentin and alpha smooth muscle actin,
but were negative for antibodies directed against S100, CD34 and CD31. Cytokeratins highlighted
the epithelial islands, but did not react with the mesenchymal proliferation. To date, fewer than
70 cases of odontogenic sarcoma have been described in the literature. To our knowledge, this is
the first report of an odontogenic malignancy showing smooth muscle differentiation.c 2006 Elsevier Ltd. All rights reserved.
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Malignant mixed odontogenic tumours are rare gnathic enti-
ties with malignant mesenchymal and benign epithelial.
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components. An odontogenic sarcoma is a mixed odonto-
genic tumour with benign epithelial and malignant mesen-
chymal components.1 The epithelial component resembles
the odontogenic epithelium of normal tooth development
or that observed in pathologic lesions such as ameloblas-
toma or ameloblastic fibroma.1 The mesenchymal compo-
nent usually exhibits features of a fibrosarcoma. If the
lesion contains dentin or enamel and dentin, the most
appropriate diagnoses would be ameloblastic dentinosar-
coma or ameloblastic odontosarcoma, respectively.1,2 The
differences exist in nomenclature rather than in prognosis.1
The term odontogenic carcinosarcoma is reserved for le-
sions with both malignant mesenchymal and odontogenic
epithelial components.
Fewer than 70 cases of odontogenic sarcoma have been
described in the literature, all of which were diagnosed as
odontogenic fibrosarcomas. To our knowledge this is the
first case report of an odontogenic sarcoma with smooth
muscle differentiation.
Case report
A 70-year-old woman underwent an extraction of the
mandibular left first molar. Two weeks later, she pre-
sented to the oral surgeon with complaints of pain at
the extraction site. Upon examination, a large, lobulated,
pink, fungating mass with foci of ulceration was observed
growing out of the extraction site (Fig. 1). A panoramic
radiograph showed a large radiolucent lesion with poorly
defined margins in the posterior mandible (Fig. 2). An
incisional biopsy was performed and submitted for histop-
athologic evaluation. Microscopic examination revealed a
malignant neoplasm consisting of oval and spindle-shaped
cells with hyperchromatic nuclei. Interspersed among the
neoplastic cells were islands of epithelium, some of which
exhibited a basaloid appearance, consistent with
odontogenic epithelium. Large areas of necrosis and
numerous mitotic figures, some of which were atypical,
were observed. Some high power fields contained 3–4
mitoses (Fig. 3). Immunohistochemical studies using for-
malin-fixed, paraffin-embedded tissue showed positive
immunoreactivity of the spindle and oval-shaped cells
for antibodies directed against vimentin and alpha smoothFigure 1 Clinical appearance prior to incisional biopsy,
showing a fungating mass on the posterior mandibular ridge.muscle actin, but these cells were negative for antibodies
directed against S100, CD34, CD31 and cytokeratin. In
contrast, the epithelial islands were highlighted by
cytokeratin antibodies. Approximately, 20–30% of the
neoplastic cells were Ki-67 positive, a measure of prolifer-
ative activity. Chest and abdomen scans were negative for
any lesions. The patient underwent a left hemi-mandibu-
lectomy with removal of the left submandibular gland.
The patient elected not to have reconstructive surgery.
At an eight-month follow-up visit, there was no evidence
of recurrent disease.Discussion
An ameloblastic fibrosarcoma is a rare mixed odontogenic
tumour with a malignant mesenchymal component.1 In this
report, the term odontogenic sarcoma with smooth muscle
differentiation is used in preference to odontogenic leiomy-
osarcoma because the latter implies smooth muscle origin
rather than smooth muscle differentiation of the ectomes-
enchymal tissue surrounding the odontogenic epithelium.
Furthermore, the epithelial component resembled odonto-
genic epithelial islands that were not ‘‘ameloblastic’’ in
appearance.
The first extensive review of the odontogenic sarcoma
was by Muller et al.3 in 1993. Subsequently, the lesion was
reviewed by Bregni et al.4 who identified 60 cases in the lit-
erature and described two new cases. Four other reports
describing one case each and the present case brings the to-
tal to 67 cases.2,5–7 The odontogenic sarcoma exhibits a
male predilection with 39 cases occurring in males (58.2%)
and 26 in females (38.8%). The gender was not stated for
two cases (3.0%). Of these, 37 cases were in the mandible
and 11 were in the maxilla.
Odontogenic sarcomas may arise from an ameloblastic fi-
broma or de novo.6 The short duration and age of the pa-
tient in this case suggest that the lesion arose de novo.
Typically, lesions present in the 2nd and 3rd decades, con-
sistent with the younger age presentation of the ameloblas-
tic fibroma.1,4 Previous studies4 reported an average age of
27.3 years with a range of 3–83 years. The five subsequently
reported cases, including the one described here, raise the
mean age to 28.9 years. Thirty-one of 58 (53.4%) well docu-
mented cases appeared to arise from a pre-existing amelob-
lastic fibroma.2–11
Based on less than 70 reported cases, ameloblastic fibro-
sarcomas are considered low-grade lesions because they
rarely metastasize but are locally aggressive lesions.2,4,6,12
However, about 20% of patients die of locally aggressive dis-
ease in 3 months to 19 years.12 Due to the high recurrence
potential, wide-surgical excision with close clinical-follow-
up are recommended.4
The current case is the first report, to our knowledge, of
an odontogenic sarcoma with documented smooth muscle
differentiation. A recently published case study reported
positive immunohistochemical reaction with CD34, but not
with smooth muscle actin antibodies.2 In contrast, the pres-
ent case was CD34-negative but SMA-positive. Due to the
limited descriptions of immunohistochemical studies in ear-
lier reports, it is possible that some of these previously doc-
umented lesions represent odontogenic sarcomas with
Figure 2 A panoramic radiograph reveals a poorly circumscribed radiolucent lesion in the left posterior mandible.
Figure 3 (A, B) Histopathologic appearance of the lesion showing hyperchromatic nuclei, numerous mitoses, and odontogenic
epithelial islands (hematoxylin and eosin stain, H & E). (C–F) Immunohistochemistry for vimentin, smooth muscle actin,
pancytokeratin and Ki-67. The spindle cell proliferation was immunoreactive with vimentin (VIM) and smooth muscle actin (SMA)
whereas the epithelial component was immunoreactive with pancytokeratin (cyk). Approximately 20–30% of the lesional cells
stained positively with Ki-67 (bar = 50 lm).
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fibrosarcomas.
In summary, odontogenic sarcomas are rare lesions that
exhibit a male predilection and are seen more frequently
in the mandible than in the maxilla. These lesions usually
develop in pre-existing ameloblastic fibromas, but de novo
lesions have also been described. The present case appearsto represent the first report of an odontogenic sarcoma with
smooth muscle differentiation.Acknowledgement
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